Ms. Wang's physical condition has been relatively good and she did not care too much, and the results were found to be HER2-positive breast cancer, which is relatively malignant and has lymph node metastasis. Although she is relatively old, she is still very resistant to mastectomy surgery, and after hesitation, she finally decided to listen to the doctor and give priority to the curative effect, and undergo neoadjuvant surgery such as chemotherapy.
When breast cancer progresses to the middle and advanced stages, the tumor is large, and total mastectomy is required to improve the survival rate of patients. The team of Shao Zhimin, director of the Department of Breast Surgery and chief physician of Fudan University Cancer Hospital, performed a total mastectomy for Ms. Wang.
After the operation, Ms. Wang had a new question: why do she need postoperative assistance after radiotherapy if the surgical effect is good**? Ms. Wang said that she has already suffered from hair loss and impaired liver function, etc., and if she continues radiotherapy, even if the cancer cells are killed, other organs will be affected.
Actually, it's a marathon. Liu Yin, deputy chief physician of the Department of Breast Surgery at Fudan University Cancer Hospital, explained that for breast cancer patients who have the opportunity to operate, the best chance is only this one time after surgery. If the patient is metastasized, it may become a lifelong disease and enter a state of inaccessibility. Even if all the tumors have regressed through the early stage, radiotherapy is still required, which is the work done to prevent the first child.